Cite
Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.
MLA
Montefiori, David C., et al. “Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.” Journal of Infectious Diseases, vol. 206, no. 3, Aug. 2012, pp. 431–41. EBSCOhost, https://doi.org/10.1093/infdis/jis367.
APA
Montefiori, D. C., Karnasuta, C., Huang, Y., Ahmed, H., Gilbert, P., de Souza, M. S., McLinden, R., Tovanabutra, S., Laurence-Chenine, A., Sanders-Buell, E., Moody, M. A., Bonsignori, M., Ochsenbauer, C., Kappes, J., Tang, H., Greene, K., Gao, H., LaBranche, C. C., Andrews, C., & Polonis, V. R. (2012). Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials. Journal of Infectious Diseases, 206(3), 431–441. https://doi.org/10.1093/infdis/jis367
Chicago
Montefiori, David C., Chitraporn Karnasuta, Ying Huang, Hasan Ahmed, Peter Gilbert, Mark S. de Souza, Robert McLinden, et al. 2012. “Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials.” Journal of Infectious Diseases 206 (3): 431–41. doi:10.1093/infdis/jis367.